combination drug
Scope
Date
~
-
Bio & Pharma
Boryung signs deal with Stendhal to launch hypertension drug in Mexico
Boryung, a South Korean pharmaceutical company, said on Monday it had signed a deal with Stendhal SA de CV, a Mexican medical specialty company, to ...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
SillaJen starts US trial of anti-cancer drug from Basilea
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico
South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...
Feb 24, 2023 (Gmt+09:00)
-
Chemical Industry
POSCO Chemical changes name to POSCO Future M
POSCO Chemical, a chemical subsidiary of the POSCO Group, announced on Friday that it had approved an agenda to change its company name to "POSCO Fu...
Feb 24, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korea to spur defense sector tech with $1.5 bn R&D investment
South Korea plans to accelerate growth in the defense industry, a future growth engine of Asia’s fourth-largest economy, by investing more tha...
Feb 23, 2023 (Gmt+09:00)
-
Future mobility
Daewoo E&C, Jeju Air kick off K-UAM Grand Challenge phase 1 project
Daewoo Engineering & Construction Co. and Jeju Air Co. have teamed up to participate in the Korean urban air mobility (K-UAM) project. The two c...
Feb 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem builds S.Korea's first plant for clinical trials
LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma wins permission from Singapore for Nabota
South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Boryung receives EU GMP certification
South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang, Synaffix ink deal to introduce ADC technology
Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Cloud computing
NHN Dooray, HandySoft join forces to develop advanced collaboration tools
NHN Dooray, a provider of online collaboration tools, has signed a memorandum of understanding (MOU) with HandySoft, Inc., South Korea's leading gro...
Feb 03, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Uplus, LS Electric partner to support S.Korea's small businesses
LG Uplus Corp., South Korea’s third-largest mobile carrier, said on Friday that it has entered into a partnership with LS Electric Co. to expa...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma submits clinical trial plan in Australia
Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, has applied to the Australian clini...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US
South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...
Feb 02, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Two premium taxi apps mull tie-up to challenge Kakao
South Korea's two premium ride hailing apps TADA and i.M are considering a merger in a bid to challenge Kakao Mobility Corp., which commands about 9...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's InCerebro to leverage AI to identify drug candidates
South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to put AI into new drug ingredient development
South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Korean startups
S.Korea's waste recycler ReCo lands $11.8 million in investment
South Korea's startup ReCo, which runs the comprehensive waste collection and transportation service UpBox, on Wednesday said it attracted Series B ...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's K-CAB to get insurance benefits in China
South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...
Jan 20, 2023 (Gmt+09:00)